% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Barz:841567,
author = {Barz, Bogdan and Liao, Qinghua and Strodel, Birgit},
title = {{P}athways of amyloid-β aggregation depend on oligomer
shape},
journal = {Journal of the American Chemical Society},
volume = {140},
number = {1},
issn = {0002-7863},
address = {Washington, DC},
publisher = {American Chemical Society},
reportid = {FZJ-2017-08605},
pages = {319–327},
year = {2018},
abstract = {One of the the main research topics related to
Alzheimer’s disease is the aggregation of the amyloid-β
peptide, which was shown to follow different pathways for
the two major alloforms of the peptide, Aβ40 and the more
toxic Aβ42. Experimental studies emphasized that oligomers
of specific sizes appear in the early aggregation process in
different quantities and might be the key toxic agents for
each of the two alloforms. We use transition networks
derived from all-atom molecular dynamics simulations to show
that the oligomers leading to the type of oligomer
distributions observed in experiments originate from compact
conformations. Extended oligomers, on the other hand,
contribute more to the production of larger aggregates thus
driving the aggregation pro cess. We further demonstrate
that differences in the aggregation pathways of the two Aβ
alloforms occur as early as during the dimer stage. The
higher solvent-exposure of hydrophobic residues in Aβ42
oligomers contributes to the different aggregation pathways
of both alloforms and also to the increased cytotoxicity of
Aβ42.},
cin = {ICS-6},
ddc = {540},
cid = {I:(DE-Juel1)ICS-6-20110106},
pnm = {553 - Physical Basis of Diseases (POF3-553)},
pid = {G:(DE-HGF)POF3-553},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:29235346},
UT = {WOS:000422813300060},
doi = {10.1021/jacs.7b10343},
url = {https://juser.fz-juelich.de/record/841567},
}